Intrexon | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Alaunos Therapeutics USD 2.06M 661K 2024-12
Amgen USD 6.21B 330M 2025-03
Arrowhead Research USD 684.22M 631.64M 2025-03
AstraZeneca USD 41.04B 168M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 14.16B 486M 2025-03
Incyte USD 3.67B 219.94M 2025-03
Ligand Pharmaceuticals USD 795.53M 34.9M 2025-03
MacroGenics USD 116.06M 4.01M 2024-12
MannKind USD -58618000 20.2M 2025-03
Merck USD 48.34B 2.02B 2025-03
Novartis USD 44.05B 605M 2024-12
Roche Holding CHF 36.16B 3.28B 2024-12
Thermo Fisher Scientific USD 49.36B 227M 2025-03
Veracyte USD 1.19B 18.97M 2025-03
Xencor USD 639.87M 37.74M 2025-03



Intrexon Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.